Your session is about to expire
← Back to Search
ESPB with Ropivacaine for Incision Site Pain
Study Summary
This trial will compare the use of ESPB to IV and oral opiates in managing pain for those undergoing surgery through a flank incision.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am allergic to certain pain medications or local anesthetics.I have scoliosis.I can understand and use a scale to rate my pain or satisfaction.I will be in the hospital for at least a day after my surgery.I have chosen not to participate in certain treatments or procedures.My health is good to moderately impaired according to the ASA classification.I am between 18 and 85 years old.I am not planning any other surgeries that require cuts on my body.I have been on pain or neurological medication for more than 3 months or use a neuromodulator.
- Group 1: Ropivicaine
- Group 2: Normal Saline
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are septuagenarians able to partake in this examination?
"Candidates between 18 and 85 years of age may qualify for the trial. Additionally, there are 22 trials tailored to individuals under 18 and 130 trials specifically designed for seniors aged 65 or older."
Has the FDA sanctioned Ropivacaine for medical use?
"Due to the fact it is a Phase 4 trial, which demonstrates that Ropivacaine has received approval from regulatory bodies, our team have given it an appropriate score of 3 on the safety scale."
Are there any vacancies remaining for potential participants in this clinical experiment?
"This clinical trial is not taking on any more participants. It was first posted in September 2018 and most recently updated in October 2022. Nonetheless, there are currently 91 trials recruiting patients with nephrectomy and 67 trials looking for volunteers to participate who have been administered Ropivacaine."
Might I be qualified for participating in this experiment?
"This research study is enrolling 40 participants that have undergone nephrectomy, ranging from 18 to 85 years of age. Qualifying criteria includes: willing and able adults between the ages of 18-85, hospitalization for at least 24 hours post operation, and having sufficient cognitive skills so as to use a Visual Analogue Scale (VAS) and complete an assessment survey."
How many people have enrolled in this trial?
"At this time, the study is no longer open for enrollment. This trial was initially posted on September 28th 2018 and had its latest update on October 10th 2022. For those interested in alternative studies, there are 91 trials recruiting patients with nephrectomy as well as 67 research projects enrolling volunteers to take part in Ropivacaine therapy."
What medical conditions usually require Ropivacaine as a treatment?
"Ropivacaine is a medication which can be administered in order to facilitate anesthesia during surgery, or for the management of labour and postoperative pain."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger